CSGALNACT2 restricts ovarian cancer migration and invasion by modulating MAPK/ERK pathway through DUSP1.
Ma M, Wang C, Wu M, Gu S, Yang J, Zhang Y, Cheng S, Xu S, Zhang M, Wu Y, Zhao Y, Tian X, Voon DC, Takahashi C, Sheng J, Wang Y.
Ma M, et al.
Cell Oncol (Dordr). 2024 Jun;47(3):897-915. doi: 10.1007/s13402-023-00903-9. Epub 2023 Dec 12.
Cell Oncol (Dordr). 2024.
PMID: 38082211
Free PMC article.